Richard Rose – Dr. Rose is an experienced healthcare executive with broad experience in biotechnology and healthcare. Dr. Rose was a Managing Director of MPM Capital, and in this capacity was responsible for biotechnology advisory and investment activities on the West coast of the U.S. and in Japan. From 1996-2000 he served as President and CEO of StemCells, Inc. (NASDAQ:Stem), a biotechnology company formerly named CytoTherapeutics. He is a Founder of SRS Capital, LLC, and HealthCapWest, Inc., merchant banking and financial advisory firms; He is also a Founder of VetMed Laboroatories, Inc. a pharmaceutical company developing FDA approved drugs for sale to the companion animal market. He has served on a number of corporate Boards including Biofem, Inc. Modex Therapeutiques ( Lausanne, Switzerland), StemCells, Inc., and the American Thoracic Society.
He is a graduate (magna cum laude) of Yale College and the Harvard Medical School where he was Associate Professor of Medicine, and Chief of the Division of Pulmonary and Critical Care Medicine at the New England Deaconess Hospital, a major Boston teaching hospital. He is a Fellow of the American College of Physicians, and is Board certified in Internal Medicine and the sub-specialties of Pulmonary Medicine and Critical Care Medicine. He is the author of over 75 scientific articles published in peer-reviewed journals, and is the author of a book on biotechnology for non-scientists. He holds an adjunct faculty appointment at UCSD School of Medicine, and a NASD broker-dealer securities license.
Dr. Rose has served on numerous advisory boards including those of Genetics Institute, the MIT Biotechnology Center, the National Heart, Lung and Blood Institute, Care Group Healthcare System in Boston, CyBios, Inc., the UCSD Cancer Center, and Arizeke, Inc. From 1992-95 he served as Vice President for Drug Development at Cytel Corporation.
Return to Our Team